(S)-nicotine increases expression ISO RGD:1349130 6480464 Nicotine results in increased expression of TWIST1 mRNA CTD PMID:23219715 17beta-estradiol decreases expression ISO RGD:1349130 6480464 Estradiol results in decreased expression of TWIST1 mRNA CTD PMID:18692832 17beta-estradiol multiple interactions ISO RGD:1349130 6480464 [Arsenic co-treated with Estradiol] results in decreased expression of TWIST1 mRNA, [Progesterone co-treated with Estradiol] results in decreased expression of TWIST1 mRNA CTD PMID:17404688 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1553211 6480464 Tetrachlorodibenzodioxin affects the expression of TWIST1 mRNA CTD PMID:24058054 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of TWIST1 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1349130 6480464 Tetrachlorodibenzodioxin affects the expression of TWIST1 mRNA CTD PMID:30203000 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1553211 6480464 Tetrachlorodibenzodioxin promotes the reaction [tributyltin results in decreased expression of TWIST1 mRNA] CTD PMID:22749964 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1553211 6480464 Tetrachlorodibenzodioxin results in increased expression of TWIST1 mRNA CTD PMID:21167638 2-ethylhexan-1-ol increases expression ISO RGD:1553211 6480464 2-ethylhexanol results in increased expression of TWIST1 mRNA CTD PMID:31445079 3-Nitrobenzanthrone affects expression ISO RGD:1349130 6480464 3-nitrobenzanthrone affects the expression of TWIST1 mRNA CTD PMID:34036453 3-Nitrobenzanthrone increases expression ISO RGD:1349130 6480464 3-nitrobenzanthrone results in increased expression of TWIST1 protein CTD PMID:34036453 4,4'-sulfonyldiphenol increases expression ISO RGD:1553211 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of TWIST1 mRNA CTD PMID:30951980 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases expression ISO RGD:1553211 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of TWIST1 mRNA CTD PMID:21167638 4-hydroxyphenyl retinamide decreases expression ISO RGD:1553211 6480464 Fenretinide results in decreased expression of TWIST1 mRNA CTD PMID:28973697 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of TWIST1 mRNA CTD PMID:24780913 7,12-dimethyltetraphene multiple interactions ISO RGD:1349130 6480464 mithramycin A inhibits the reaction [9 more ... CTD PMID:29663660 7,12-dimethyltetraphene increases expression ISO RGD:1349130 6480464 9 more ... CTD PMID:29663660 afimoxifene multiple interactions ISO RGD:1349130 6480464 afimoxifene inhibits the reaction [Estrogens results in decreased expression of TWIST1 mRNA] CTD PMID:21233418 aflatoxin B1 affects expression ISO RGD:1349130 6480464 Aflatoxin B1 affects the expression of TWIST1 protein CTD PMID:20106945 aflatoxin B1 decreases expression ISO RGD:1349130 6480464 Aflatoxin B1 results in decreased expression of TWIST1 mRNA CTD PMID:28965971 aflatoxin B1 decreases methylation ISO RGD:1349130 6480464 Aflatoxin B1 results in decreased methylation of TWIST1 gene CTD PMID:27153756 aldehydo-D-glucose decreases expression ISO RGD:1349130 6480464 Glucose deficiency results in decreased expression of TWIST mRNA CTD PMID:35427737 all-trans-retinoic acid increases expression ISO RGD:1349130 6480464 Tretinoin results in increased expression of TWIST1 mRNA CTD PMID:21934132 , PMID:23724009 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of TWIST1 mRNA CTD PMID:16483693 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:1349130 6480464 pyrazolanthrone inhibits the reaction [thymoquinone results in decreased expression of TWIST1 protein] CTD PMID:27060453 aristolochic acid increases expression ISO RGD:1349130 6480464 aristolochic acid I results in increased expression of TWIST1 mRNA CTD PMID:33212167 arsane decreases response to substance ISO RGD:1349130 6480464 TWIST1 protein results in decreased susceptibility to Arsenic CTD PMID:19806464 arsane multiple interactions ISO RGD:1349130 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TWIST1 protein] more ... CTD PMID:32645460 more ... arsenic atom decreases response to substance ISO RGD:1349130 6480464 TWIST1 protein results in decreased susceptibility to Arsenic CTD PMID:19806464 arsenic atom multiple interactions ISO RGD:1349130 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TWIST1 protein] more ... CTD PMID:32645460 more ... arsenite(3-) increases methylation ISO RGD:1349130 6480464 arsenite results in increased methylation of TWIST1 promoter CTD PMID:23974009 belinostat increases expression ISO RGD:1349130 6480464 belinostat results in increased expression of TWIST1 protein CTD PMID:23671600 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of TWIST1 mRNA CTD PMID:21839799 benzo[a]pyrene affects methylation ISO RGD:1349130 6480464 Benzo(a)pyrene affects the methylation of TWIST1 promoter CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:1553211 6480464 Benzo(a)pyrene results in decreased expression of TWIST1 mRNA CTD PMID:22610609 benzo[a]pyrene increases expression ISO RGD:1349130 6480464 Benzo(a)pyrene results in increased expression of TWIST1 mRNA, Benzo(a)pyrene results in increased expression of TWIST1 protein CTD PMID:24847786 bisphenol A increases methylation ISO RGD:1349130 6480464 bisphenol A results in increased methylation of TWIST1 gene CTD PMID:22576693 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of TWIST1 mRNA CTD PMID:34947998 bisphenol A increases expression ISO RGD:1553211 6480464 bisphenol A results in increased expression of TWIST1 mRNA CTD PMID:30951980 bisphenol A multiple interactions ISO RGD:1553211 6480464 [bisphenol A co-treated with LIF protein] results in decreased expression of TWIST1 mRNA CTD PMID:30951980 bisphenol A affects methylation ISO RGD:1553211 6480464 bisphenol A affects the methylation of TWIST1 promoter CTD PMID:27334623 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of TWIST1 mRNA CTD PMID:25181051 more ... bisphenol A decreases expression ISO RGD:1349130 6480464 bisphenol A results in decreased expression of TWIST1 mRNA CTD PMID:22576693 , PMID:26363213 bisphenol F increases expression ISO RGD:1553211 6480464 bisphenol F results in increased expression of TWIST1 mRNA CTD PMID:30951980 cadmium dichloride increases expression ISO RGD:1553211 6480464 Cadmium Chloride results in increased expression of TWIST1 mRNA CTD PMID:20478370 cadmium dichloride affects expression ISO RGD:1349130 6480464 Cadmium Chloride affects the expression of TWIST1 mRNA CTD PMID:23828170 calcitriol decreases expression ISO RGD:1349130 6480464 Calcitriol results in decreased expression of TWIST1 mRNA CTD PMID:26485663 CGP 52608 multiple interactions ISO RGD:1349130 6480464 CGP 52608 promotes the reaction [RORA protein binds to TWIST1 gene] CTD PMID:28238834 choline multiple interactions ISO RGD:1553211 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TWIST1 gene CTD PMID:20938992 chromium(6+) decreases expression ISO RGD:1349130 6480464 chromium hexavalent ion results in decreased expression of TWIST1 protein CTD PMID:23518002 cisplatin increases expression ISO RGD:1349130 6480464 Cisplatin results in increased expression of TWIST1 mRNA CTD PMID:21618587 cisplatin decreases expression ISO RGD:1349130 6480464 Cisplatin results in decreased expression of TWIST1 mRNA CTD PMID:27392435 cisplatin multiple interactions ISO RGD:1349130 6480464 U 0126 inhibits the reaction [Cisplatin results in increased expression of TWIST1 mRNA] CTD PMID:21618587 cobalt dichloride multiple interactions ISO RGD:1349130 6480464 cobaltous chloride results in increased expression of and affects the localization of TWIST1 protein, tetraethylenepentamine inhibits the reaction [cobaltous chloride results in increased expression of and affects the localization of TWIST1 protein] CTD PMID:26174737 coumestrol multiple interactions ISO RGD:1349130 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TWIST1 mRNA CTD PMID:19167446 crizotinib decreases response to substance ISO RGD:1349130 6480464 TWIST1 protein results in decreased susceptibility to crizotinib CTD PMID:22155737 D-glucose decreases expression ISO RGD:1349130 6480464 Glucose deficiency results in decreased expression of TWIST mRNA CTD PMID:35427737 dexamethasone increases expression ISO RGD:1349130 6480464 Dexamethasone results in increased expression of TWIST1 mRNA CTD PMID:25047013 diallyl trisulfide decreases expression ISO RGD:1349130 6480464 diallyl trisulfide results in decreased expression of TWIST1 protein CTD PMID:27566995 diallyl trisulfide multiple interactions ISO RGD:1349130 6480464 LDHA protein inhibits the reaction [diallyl trisulfide results in decreased expression of TWIST1 protein] CTD PMID:27566995 dieckol decreases expression ISO RGD:1349130 6480464 dieckol results in decreased expression of TWIST1 protein CTD PMID:31291034 dioxygen increases expression ISO RGD:1349130 6480464 [Oxygen deficiency results in increased expression of CA9 mRNA] which results in increased expression of TWIST1 mRNA CTD PMID:26305601 dioxygen multiple interactions ISO RGD:1349130 6480464 CA9 mutant form inhibits the reaction [[Oxygen deficiency results in increased expression of CA9 mRNA] which results in increased expression of TWIST1 mRNA] CTD PMID:26305601 dorsomorphin multiple interactions ISO RGD:1349130 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases expression ISO RGD:1349130 6480464 Doxorubicin results in increased expression of TWIST1 mRNA CTD PMID:29803840 endosulfan multiple interactions ISO RGD:1349130 6480464 LY2109761 inhibits the reaction [Endosulfan results in increased expression of TWIST1 protein] CTD PMID:32413665 endosulfan increases expression ISO RGD:1349130 6480464 Endosulfan results in increased expression of TWIST1 protein CTD PMID:32413665 Enterolactone multiple interactions ISO RGD:1349130 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TWIST1 mRNA CTD PMID:19167446 erlotinib hydrochloride decreases response to substance ISO RGD:1553211 6480464 TWIST1 protein results in decreased susceptibility to Erlotinib Hydrochloride CTD PMID:30171258 erlotinib hydrochloride multiple interactions ISO RGD:1349130 6480464 [TWIST1 protein results in decreased susceptibility to Erlotinib Hydrochloride] which results in decreased cleavage of PARP1 protein, TWIST1 protein inhibits the reaction [Erlotinib Hydrochloride results in increased cleavage of PARP1 protein] CTD PMID:30171258 erlotinib hydrochloride decreases response to substance ISO RGD:1349130 6480464 TWIST1 protein results in decreased susceptibility to Erlotinib Hydrochloride CTD PMID:30171258 erlotinib hydrochloride increases expression ISO RGD:1553211 6480464 Erlotinib Hydrochloride results in increased expression of TWIST1 protein CTD PMID:30171258 erlotinib hydrochloride multiple interactions ISO RGD:1553211 6480464 [TWIST1 protein results in decreased susceptibility to Erlotinib Hydrochloride] which results in decreased cleavage of CASP3 protein CTD PMID:30171258 finasteride multiple interactions EXP 6480464 Finasteride inhibits the reaction [Testosterone results in increased expression of TWIST1 mRNA] CTD PMID:27866977 flurbiprofen decreases expression ISO RGD:1553211 6480464 Flurbiprofen results in decreased expression of TWIST1 mRNA CTD PMID:16949054 folic acid multiple interactions ISO RGD:1553211 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TWIST1 gene CTD PMID:20938992 fonofos increases methylation ISO RGD:1349130 6480464 Fonofos results in increased methylation of TWIST1 promoter CTD PMID:22847954 gefitinib affects response to substance ISO RGD:1349130 6480464 TWIST1 protein affects the susceptibility to Gefitinib CTD PMID:30993382 glucose decreases expression ISO RGD:1349130 6480464 Glucose deficiency results in decreased expression of TWIST mRNA CTD PMID:35427737 Honokiol decreases expression ISO RGD:1349130 6480464 honokiol results in decreased expression of TWIST protein CTD PMID:34973135 isobutanol multiple interactions ISO RGD:1349130 6480464 [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of TWIST1 mRNA CTD PMID:29432896 L-methionine multiple interactions ISO RGD:1553211 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TWIST1 gene CTD PMID:20938992 lapatinib multiple interactions ISO RGD:1349130 6480464 Lapatinib inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TWIST1 mRNA] more ... CTD PMID:33396024 losartan multiple interactions ISO RGD:1553211 6480464 Losartan inhibits the reaction [AGT protein results in increased expression of TWIST1 protein] CTD PMID:28578904 losartan multiple interactions ISO RGD:1349130 6480464 Losartan inhibits the reaction [AGT protein results in increased expression of TWIST1 protein] CTD PMID:28578904 LY294002 multiple interactions ISO RGD:1349130 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TWIST1 protein], 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [CXCL8 protein promotes the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TWIST1 protein]] CTD PMID:33396024 malathion increases expression ISO RGD:1349130 6480464 Malathion results in increased expression of TWIST1 mRNA CTD PMID:32069766 melatonin multiple interactions ISO RGD:1349130 6480464 TWIST1 protein affects the reaction [Melatonin results in decreased expression of PROM1 protein] CTD PMID:30421542 mercury dibromide increases expression ISO RGD:1349130 6480464 mercuric bromide results in increased expression of TWIST1 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:1349130 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TWIST1 mRNA CTD PMID:27188386 methylmercury chloride increases expression ISO RGD:1349130 6480464 methylmercuric chloride results in increased expression of TWIST1 mRNA CTD PMID:28001369 methylmercury chloride decreases expression ISO RGD:1349130 6480464 methylmercuric chloride results in decreased expression of TWIST1 mRNA CTD PMID:34089799 N-ethyl-N-nitrosourea increases mutagenesis ISO RGD:1553211 6480464 Ethylnitrosourea results in increased mutagenesis of TWIST1 gene CTD PMID:16724327 N-methyl-N-nitrosourea multiple interactions EXP 6480464 [Methylnitrosourea co-treated with Testosterone] results in increased expression of TWIST1 mRNA, Quercetin inhibits the reaction [[Methylnitrosourea co-treated with Testosterone] results in increased expression of TWIST1 mRNA] CTD PMID:25164625 niclosamide decreases expression ISO RGD:1349130 6480464 Niclosamide results in decreased expression of TWIST1 protein CTD PMID:29480568 nicotine increases expression ISO RGD:1349130 6480464 Nicotine results in increased expression of TWIST1 mRNA CTD PMID:23219715 osimertinib decreases response to substance ISO RGD:1349130 6480464 TWIST1 protein results in decreased susceptibility to osimertinib CTD PMID:30171258 osimertinib affects response to substance ISO RGD:1349130 6480464 TWIST1 protein affects the susceptibility to osimertinib CTD PMID:30993382 osimertinib multiple interactions ISO RGD:1349130 6480464 [TWIST1 protein results in decreased susceptibility to osimertinib] which results in decreased cleavage of PARP1 protein, TWIST1 protein inhibits the reaction [osimertinib results in increased cleavage of PARP1 protein] CTD PMID:30171258 ouabain increases expression ISO RGD:1349130 6480464 Ouabain results in increased expression of TWIST1 mRNA CTD PMID:33760381 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of TWIST1 mRNA CTD PMID:25729387 p-chloromercuribenzoic acid multiple interactions ISO RGD:1349130 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TWIST1 mRNA CTD PMID:27188386 Pachymic acid multiple interactions ISO RGD:1553211 6480464 pachymic acid analog inhibits the reaction [AGT protein results in increased expression of TWIST1 protein] CTD PMID:28578904 Pachymic acid multiple interactions ISO RGD:1349130 6480464 pachymic acid analog inhibits the reaction [AGT protein results in increased expression of TWIST1 protein] CTD PMID:28578904 panobinostat multiple interactions ISO RGD:1349130 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TWIST1 mRNA CTD PMID:27188386 panobinostat increases expression ISO RGD:1349130 6480464 panobinostat results in increased expression of TWIST1 mRNA CTD PMID:26272509 paracetamol increases expression ISO RGD:1553211 6480464 Acetaminophen results in increased expression of TWIST1 mRNA CTD PMID:17585979 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of TWIST1 mRNA CTD PMID:33387578 parathion increases methylation ISO RGD:1349130 6480464 Parathion results in increased methylation of TWIST1 promoter CTD PMID:22847954 phenylmercury acetate increases expression ISO RGD:1349130 6480464 Phenylmercuric Acetate results in increased expression of TWIST1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1349130 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TWIST1 mRNA CTD PMID:27188386 pirinixic acid increases expression ISO RGD:1553211 6480464 pirinixic acid results in increased expression of TWIST1 mRNA CTD PMID:20813756 poly(I:C) decreases expression EXP 6480464 Poly I-C results in decreased expression of TWIST1 mRNA CTD PMID:26923065 progesterone multiple interactions ISO RGD:1349130 6480464 [Progesterone co-treated with Estradiol] results in decreased expression of TWIST1 mRNA CTD PMID:17404688 , PMID:18692832 progesterone decreases expression ISO RGD:1349130 6480464 Progesterone results in decreased expression of TWIST1 mRNA CTD PMID:17404688 , PMID:18692832 quercetin multiple interactions EXP 6480464 Quercetin inhibits the reaction [[Methylnitrosourea co-treated with Testosterone] results in increased expression of TWIST1 mRNA] CTD PMID:25164625 quercetin decreases expression ISO RGD:1349130 6480464 Quercetin results in decreased expression of TWIST1 protein CTD PMID:22422628 reparixin multiple interactions ISO RGD:1349130 6480464 reparixin inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TWIST1 protein] CTD PMID:33396024 SB 203580 multiple interactions ISO RGD:1349130 6480464 SB 203580 inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TWIST1 mRNA] more ... CTD PMID:27060453 , PMID:33396024 SB 431542 multiple interactions ISO RGD:1349130 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 serpentine asbestos increases expression ISO RGD:1349130 6480464 Asbestos, Serpentine results in increased expression of TWIST1 protein CTD PMID:30609805 sodium arsenite multiple interactions ISO RGD:1349130 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TWIST1 protein] more ... CTD PMID:22662215 more ... sodium arsenite increases expression ISO RGD:1349130 6480464 sodium arsenite results in increased expression of TWIST1 mRNA, sodium arsenite results in increased expression of TWIST1 protein CTD PMID:22662215 , PMID:32844245 sorafenib decreases expression ISO RGD:1553211 6480464 sorafenib results in decreased expression of TWIST1 mRNA CTD PMID:21360571 stattic multiple interactions ISO RGD:1349130 6480464 stattic inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TWIST1 mRNA] more ... CTD PMID:33396024 sunitinib decreases expression ISO RGD:1349130 6480464 Sunitinib results in decreased expression of TWIST1 mRNA CTD PMID:31533062 Swertiamarin multiple interactions EXP 6480464 swertiamarin inhibits the reaction [Testosterone results in increased expression of TWIST1 mRNA] CTD PMID:27866977 terbufos increases methylation ISO RGD:1349130 6480464 terbufos results in increased methylation of TWIST1 promoter CTD PMID:22847954 testosterone multiple interactions EXP 6480464 [Methylnitrosourea co-treated with Testosterone] results in increased expression of TWIST1 mRNA more ... CTD PMID:25164625 , PMID:27866977 testosterone increases expression EXP 6480464 Testosterone results in increased expression of TWIST1 mRNA CTD PMID:27866977 tetraethylenepentamine decreases expression ISO RGD:1553211 6480464 tetraethylenepentamine results in decreased expression of TWIST1 protein CTD PMID:26174737 tetraethylenepentamine multiple interactions ISO RGD:1349130 6480464 tetraethylenepentamine inhibits the reaction [cobaltous chloride results in increased expression of and affects the localization of TWIST1 protein] CTD PMID:26174737 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of TWIST1 mRNA CTD PMID:34492290 thymoquinone multiple interactions ISO RGD:1349130 6480464 pyrazolanthrone inhibits the reaction [thymoquinone results in decreased expression of TWIST1 protein], SB 203580 inhibits the reaction [thymoquinone results in decreased expression of TWIST1 protein] CTD PMID:27060453 thymoquinone decreases expression ISO RGD:1349130 6480464 thymoquinone results in decreased expression of TWIST1 protein CTD PMID:27060453 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of TWIST1 mRNA CTD PMID:25729387 tributylstannane multiple interactions ISO RGD:1553211 6480464 Tetrachlorodibenzodioxin promotes the reaction [tributyltin results in decreased expression of TWIST1 mRNA] CTD PMID:22749964 tributylstannane decreases expression ISO RGD:1553211 6480464 tributyltin results in decreased expression of TWIST1 mRNA CTD PMID:22749964 trichostatin A increases expression ISO RGD:1349130 6480464 trichostatin A results in increased expression of TWIST1 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1349130 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TWIST1 mRNA CTD PMID:27188386 undecane increases expression EXP 6480464 undecane results in increased expression of TWIST1 protein CTD PMID:17337753 valproic acid increases expression ISO RGD:1553211 6480464 Valproic Acid results in increased expression of TWIST1 mRNA CTD PMID:24896083 , PMID:31445079 valproic acid increases expression ISO RGD:1349130 6480464 Valproic Acid results in increased expression of TWIST1 mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO RGD:1349130 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TWIST1 mRNA CTD PMID:27188386 vorinostat increases expression ISO RGD:1349130 6480464 vorinostat results in increased expression of TWIST1 mRNA CTD PMID:26272509 zearalenone decreases expression ISO RGD:1349130 6480464 Zearalenone results in decreased expression of TWIST1 mRNA CTD PMID:28965971
